CN117547505A - Preparation method of massage cream for relaxing and activating channels and collaterals - Google Patents
Preparation method of massage cream for relaxing and activating channels and collaterals Download PDFInfo
- Publication number
- CN117547505A CN117547505A CN202410037706.9A CN202410037706A CN117547505A CN 117547505 A CN117547505 A CN 117547505A CN 202410037706 A CN202410037706 A CN 202410037706A CN 117547505 A CN117547505 A CN 117547505A
- Authority
- CN
- China
- Prior art keywords
- relaxing
- massage cream
- parts
- muscles
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006071 cream Substances 0.000 title claims abstract description 38
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 230000003213 activating effect Effects 0.000 title description 14
- 239000003755 preservative agent Substances 0.000 claims abstract description 29
- 230000002335 preservative effect Effects 0.000 claims abstract description 29
- 210000003205 muscle Anatomy 0.000 claims abstract description 25
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 16
- 235000018417 cysteine Nutrition 0.000 claims abstract description 11
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 11
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000005770 Eugenol Substances 0.000 claims abstract description 10
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960002217 eugenol Drugs 0.000 claims abstract description 10
- 239000000839 emulsion Substances 0.000 claims abstract description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 36
- 239000000284 extract Substances 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 12
- 239000003086 colorant Substances 0.000 claims description 12
- 239000002826 coolant Substances 0.000 claims description 12
- 239000003974 emollient agent Substances 0.000 claims description 12
- 239000003906 humectant Substances 0.000 claims description 12
- 239000002562 thickening agent Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical group CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 8
- 229940041616 menthol Drugs 0.000 claims description 8
- HKUFIYBZNQSHQS-UHFFFAOYSA-N n-octadecyloctadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCC HKUFIYBZNQSHQS-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 240000007164 Salvia officinalis Species 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 235000005412 red sage Nutrition 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 6
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 6
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims description 6
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 6
- 241001071795 Gentiana Species 0.000 claims description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 6
- 229960000458 allantoin Drugs 0.000 claims description 6
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 6
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 6
- 239000000686 essence Substances 0.000 claims description 6
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 6
- 229940107131 ginseng root Drugs 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 6
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 229940119485 safflower extract Drugs 0.000 claims description 6
- 229940078465 vanillyl butyl ether Drugs 0.000 claims description 6
- 239000001628 zingiber officinale rosc. oil terpeneless Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 241000244355 Ligusticum Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 201000004624 Dermatitis Diseases 0.000 abstract description 4
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003995 emulsifying agent Substances 0.000 abstract description 3
- 239000003921 oil Substances 0.000 abstract description 3
- 206010052428 Wound Diseases 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 abstract description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 230000000202 analgesic effect Effects 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract description 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 208000010668 atopic eczema Diseases 0.000 abstract description 2
- 230000001054 cortical effect Effects 0.000 abstract description 2
- 230000002439 hemostatic effect Effects 0.000 abstract description 2
- 235000020939 nutritional additive Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000028327 secretion Effects 0.000 abstract description 2
- 206010040872 skin infection Diseases 0.000 abstract description 2
- 229960003080 taurine Drugs 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 12
- 210000001503 joint Anatomy 0.000 description 12
- 239000000203 mixture Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 4
- 229940064221 ligusticum wallichii root extract Drugs 0.000 description 4
- 244000178870 Lavandula angustifolia Species 0.000 description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 240000000530 Alcea rosea Species 0.000 description 2
- 235000017334 Alcea rosea Nutrition 0.000 description 2
- 235000017303 Althaea rosea Nutrition 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000911175 Citharexylum caudatum Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 240000000907 Musa textilis Species 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940023019 aconite Drugs 0.000 description 1
- -1 acryl Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- CFAFEJHONLMPQY-UHFFFAOYSA-N beta-Dimethylamino-aethan-alpha-sulfonsaeure Natural products CN(C)CCS(O)(=O)=O CFAFEJHONLMPQY-UHFFFAOYSA-N 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000177 juniperus communis l. berry Substances 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a preparation method of a massage cream for relaxing the muscles and joints and belongs to the field of massage cream. The emulsion preservative with the functions of both the emulsifier and the preservative contains taurine: antioxidant, it enhances cortical cell activity, inhibits skin allergy, and also is anti-inflammatory; eugenol: has antibacterial, analgesic, antiinflammatory, hemostatic effects, and can be used for controlling oil secretion and treating skin infection; cysteine: is an amino acid with antioxidant effect, and can remove free radicals; in addition, cysteine can also be used for treating wounds, preventing eczema and the like, and can be used as a nutritional additive and an anti-inflammatory agent; therefore, the emulsifying preservative can reduce the dosage and variety of the emulsifying preservative, so that the variety of low-temperature raw materials of the massage cream for relaxing the muscles and joints is reduced, the cost is reduced, and the efficacy is improved.
Description
Technical Field
The invention relates to the field of massage cream, in particular to a preparation method of massage cream for relaxing the muscles and joints.
Background
The massage cream for relaxing the muscles and joints and activating the collaterals is mainly used for treating pain caused by common aseptic inflammation in clinic, can also be applied to knee osteoarthritis, cervical spondylosis, lumbago and skelalgia and scapulohumeral periarthritis, and can also be used for treating limb joint pain and diseases with unfavorable activities caused by blood stasis and swelling and pain in the later stage of traumatic injury; the massage cream for relaxing the muscles and joints is externally applied to the pain parts, most of the massage cream can play a role in relieving pain, and also can play roles in promoting inflammatory absorption, activating blood circulation to dissipate blood stasis and dredging collaterals to relieve pain.
Chinese patent CN105079760B: discloses lavender massage cream for soothing channels and activating collaterals. The lavender massage cream for soothing channels and activating collaterals comprises the following components: water, glycerin, lavandula angustifolia essential oil, safflower oil, ginger oil, white oil, xanthan gum, dodecyl glucoside, polyglycerol-2-dimer hydroxystearate, menthol, linalool, squalane, sesame seed oil, gluconic acid, sodium benzoate, potassium sorbate, camphor, juniper berry extract, hollyhock, magnolia bark root extract, witch hazel extract, calcium gluconate, geraniol, limonene, gluconolactone, hollyhock root extract, and abaca root extract.
Chinese patent CN111617182a: the invention discloses a tendon relaxing and collateral activating active plaster which comprises the following components in parts by weight: 8-15% of konjaku flour, 19-27% of gardenia powder, 26-37% of rhizoma paridis powder, 3-5% of camphor, 3-7% of menthol and 21-28% of vaseline.
Chinese patent CN105213242a: the massage cream comprises the following components in parts by weight: 5-20 parts of Sichuan green, 10-20 parts of ginkgo, 25-50 parts of red sage root, 5-10 parts of safflower, 20-40 parts of brown sugar, 10-25 parts of ginger, 30-50 parts of red date, 10-30 parts of aconite, 30-60 parts of vaseline and 200-400 parts of water.
The massage cream for relaxing the channels and activating collaterals prepared by the above patent and the prior art has unsatisfactory effects on swelling, pain, soothing and calming the skin and the like, and has low treatment efficiency.
Disclosure of Invention
In order to solve the problems, the invention provides a preparation method of massage cream for relaxing the muscles and joints, which comprises the following operation steps:
s1: weighing 60-80 parts by weight of water, 0.0001-0.001 part by weight of safflower extract, 0.0001-0.001 part by weight of ginseng root extract, 0.0001-0.001 part by weight of red sage root extract, 0.0001-0.001 part by weight of ligusticum rhizome root extract, 0.0001-0.001 part by weight of radix paeoniae rubra root extract, 0.001-0.003 part by weight of butanediol, 0.001-0.005 part by weight of 1, 2-hexanediol, emollient, humectant, thickener, thermal sensitizer and 0.07-0.7 part by weight of emulsifying preservative, adding into a vacuum emulsifying pot, mixing and stirring for 10-30min;
s2: heating to 50-70deg.C, stirring for 60-90min, homogenizing for 30-60min;
s3: finally, 0.01 to 0.1 part of essence, cooling agent and coloring agent are added and stirred for 10 to 20 minutes to obtain the massage cream for relaxing the muscles and joints.
Preferably, the emollient is: 1-5 parts of isopropyl palmitate, 0.1-0.5 part of tocopheryl acetate, 0.02-0.2 part of propylene glycol, 0.001-0.01 part of gentian extract and 0.01-0.1 part of ginger root oil.
Preferably, the humectant is: 1-4 parts of glycerin, 1-3 parts of propylene glycol and 0.02-0.2 part of allantoin.
Preferably, the preparation method of the emulsion preservative comprises the following steps:
adding 3-6 parts of acryloyldimethyl taurine, 16-32 parts of eugenol, 17-34 parts of cysteine, 0.003-0.06 part of dioctadecylamine, 0.6-2.4 parts of triethanolamine and 200-240 parts of ethanol into a dry three-neck flask according to parts by weight; the reaction temperature is controlled at 50-60 ℃, nitrogen is introduced for protection in the reaction process, the reaction time is 20-60min, and then ethanol is distilled to obtain the emulsified preservative.
Preferably, the thermal sensitizer is 0.06-0.12 parts of vanillyl butyl ether.
Preferably, the thickener is 0.1-0.5 parts of xanthan gum.
Preferably, the cooling agent is menthol 0.01-0.04 parts.
Preferably, the colorant is: 0.001-0.01 part of CI19140, 0.0005-0.002 part of CI16255, 0.0001-0.0006 part of CI 42090.
The reaction mechanism of the emulsion preservative is as follows: the acryl dimethyl taurine and the eugenol respectively undergo sulfhydryl-alkene addition reaction with cysteine; performing amino-alkene addition reaction with dioctadecylamine; an emulsified preservative with both the functions of an emulsifier and a preservative is obtained.
In summary, the present application has the following beneficial effects:
1. the massage cream for relaxing the muscles and activating the collaterals, which is prepared by the invention, is matched with a massage technique for local external use, can relieve the symptoms of local muscle adhesion, calcification and the like which occur after local soft tissue injury occurs after trauma, and has conditioning effects on joint swelling, pain, limited movement and the like caused by osteoarthritis;
2. the massage cream for relaxing the muscles and joints prepared by the invention can be externally rubbed to treat lumbar postoperative lower back pain, has the effects of activating blood circulation, removing obstruction in collaterals, removing stasis, relieving pain, soothing and calming skin and the like, and can be matched with massage manipulation to adjust the internal and external balance;
3. the emulsion preservative with the functions of both the emulsifier and the preservative contains taurine: antioxidant, it enhances cortical cell activity, inhibits skin allergy, and also is anti-inflammatory; eugenol: has antibacterial, analgesic, antiinflammatory, hemostatic effects, and can be used for controlling oil secretion and treating skin infection; cysteine: is an amino acid with antioxidant effect, and can remove free radicals; in addition, cysteine can also be used for treating wounds, preventing eczema and the like, and can be used as a nutritional additive and an anti-inflammatory agent; therefore, the emulsifying preservative can reduce the dosage and variety of the emulsifying preservative, so that the variety of low-temperature raw materials of the massage cream for relaxing the muscles and joints is reduced, the cost is reduced, and the efficacy is improved.
Detailed Description
The technical solutions of the present invention will be clearly and completely described in connection with the embodiments, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
In the embodiment, the massage is used for treating lumbar postoperative lower back pain by combining with meridian-soothing and collateral-activating massage cream by external rubbing, and the curative effect is checked for 70 people: 35 men and 35 women; average 7 groups of 10 people: 5 men and 5 women, performing a test; age 35-70 years, 1 week is a course of treatment, 3 courses of treatment altogether;
pain grades were: mild, moderate, severe;
the curative effect grade is as follows: the cure is changed from severe to mild, the pain is reduced by 1 degree to effective, and the pain is not improved to ineffective.
Example 1, a preparation method of a massage cream for relaxing the muscles and joints, which comprises the following steps:
s1: weighing 60g of water, 0.0001g of safflower extract, 0.0001g of ginseng root extract, 0.0001g of red sage root extract, 0.0001g of ligusticum wallichii root extract, 0.0001g of radix paeoniae rubra root extract, 0.001g of butanediol, 0.001g of 1, 2-hexanediol, an emollient, a humectant, a thickener, a thermal sensitizer and 0.07g of emulsifying preservative, adding into a vacuum emulsifying pot, mixing and stirring for 10min;
s2: heating to 50deg.C, stirring for 60min, and homogenizing for 30min;
s3: finally, 0.01g of essence, cooling agent and coloring agent are added and stirred for 10min to obtain the massage cream for relaxing the channels and activating the collaterals.
The emollient is as follows: 1g isopropyl palmitate, 0.1g tocopheryl acetate, 0.02g propylene glycol, 0.001g gentian extract, 0.01g ginger root oil.
The humectant is as follows: a mixture of 1g glycerol, 1g propylene glycol, 0.02g allantoin.
The preparation method of the emulsion preservative comprises the following steps:
into a dry three-neck flask, 3g of acryloyldimethyl taurine, 16g of eugenol, 17g of cysteine, 0.003g of dioctadecylamine, 0.6g of triethanolamine and 200g of ethanol were added; the reaction temperature is controlled at 50 ℃, nitrogen is introduced for protection in the reaction process, the reaction time is 20min, and then ethanol is distilled, so that the emulsified preservative is obtained.
The thermal sensitizer is 0.06g of vanillyl butyl ether.
The thickener is 0.1g of xanthan gum.
The cooling agent is menthol 0.01 g.
The coloring agent is as follows: 0.001g of CI19140, 0.0005g of CI16255, 0.0001g of CI42090.
Example 2, a preparation method of a massage cream for relaxing the muscles and joints, which comprises the following steps:
s1: 65g of water, 0.0005g of safflower extract, 0.0005g of ginseng root extract, 0.0005g of red sage root extract, 0.0005g of ligusticum wallichii root extract, 0.0005g of radix paeoniae rubra root extract, 0.002g of butanediol, 0.002g of 1, 2-hexanediol, an emollient, a humectant, a thickener, a thermal sensitizer and 0.2g of emulsifying preservative are weighed, added into a vacuum emulsifying pot, mixed and stirred for 15min;
s2: heating to 55deg.C, stirring for 70min, homogenizing for 40min;
s3: finally, 0.05g of essence, cooling agent and coloring agent are added and stirred for 15min to obtain the massage cream for relaxing the channels and activating the collaterals.
The emollient is as follows: a mixture of 2g isopropyl palmitate, 0.2g tocopheryl acetate, 0.1g propylene glycol, 0.005g gentian extract, 0.05g ginger root oil.
The humectant is as follows: a mixture of 2g glycerol, 2g propylene glycol, 0.1g allantoin.
The preparation method of the emulsion preservative comprises the following steps:
into a dry three-neck flask, 4g of acryloyldimethyl taurine, 22g of eugenol, 23g of cysteine, 0.2g of dioctadecylamine, 1g of triethanolamine and 210g of ethanol are added; the reaction temperature is controlled at 55 ℃, nitrogen is introduced for protection in the reaction process, the reaction time is 30min, and then ethanol is distilled, so that the emulsified preservative is obtained.
The thermal sensitizer is 0.08g of vanillyl butyl ether.
The thickener is 0.2g of xanthan gum.
The cooling agent is menthol 0.02 g.
The coloring agent is as follows: 0.005g of CI19140, 0.001g of CI16255, 0.0002g of CI42090.
Example 3, a preparation method of a massage cream for relaxing the muscles and joints, which comprises the following steps:
s1: weighing 75g of water, 0.0008g of safflower extract, 0.0008g of ginseng root extract, 0.0008g of red sage root extract, 0.0008g of ligusticum wallichii root extract, 0.0008g of radix paeoniae rubrathe root extract, 0.002g of butanediol, 0.004g of 1, 2-hexanediol, an emollient, a humectant, a thickener, a heat sensitizer and 0.5g of emulsifying preservative, adding into a vacuum emulsifying pot, mixing and stirring for 25min;
s2: heating to 65deg.C, stirring for 80min, homogenizing for 50min;
s3: finally, 0.08g of essence, cooling agent and coloring agent are added and stirred for 15min to obtain the massage cream for relaxing the channels and activating the collaterals.
The emollient is as follows: a mixture of 4g isopropyl palmitate, 0.4g tocopheryl acetate, 0.15g propylene glycol, 0.008g gentian extract, 0.08g ginger root oil.
The humectant is as follows: 3g of glycerol, 2g of propylene glycol, 0.15g of allantoin.
The preparation method of the emulsion preservative comprises the following steps:
into a dry three-neck flask, 5g of acryloyldimethyl taurine, 28g of eugenol, 30g of cysteine, 0.04g of dioctadecylamine, 2g of triethanolamine and 230g of ethanol are added; the reaction temperature is controlled at 55 ℃, nitrogen is introduced for protection in the reaction process, the reaction time is 50min, and then ethanol is distilled to obtain the emulsified preservative.
The thermal sensitizer is 0.1g of vanillyl butyl ether.
The thickener is 0.4g of xanthan gum.
The cooling agent is menthol 0.03 g.
The coloring agent is as follows: 0.008g of CI19140, 0.0015g of CI16255 and 0.0005g of CI42090.
Example 4, a preparation method of a massage cream for relaxing the muscles and joints, which comprises the following steps:
s1: weighing 80g of water, 0.001g of safflower extract, 0.001g of ginseng root extract, 0.001g of red sage root extract, 0.001g of ligusticum wallichii root extract, 0.001g of radix paeoniae rubra root extract, 0.003g of butanediol, 0.005g of 1, 2-hexanediol, an emollient, a humectant, a thickener, a thermal sensitizer and 0.7g of emulsifying preservative, adding into a vacuum emulsifying pot, mixing and stirring for 30min;
s2: heating to 70deg.C, stirring for 90min, and homogenizing for 60min;
s3: finally, 0.1g of essence, cooling agent and coloring agent are added and stirred for 20min to obtain the massage cream for relaxing the channels and activating the collaterals.
The emollient is as follows: a mixture of 5g isopropyl palmitate, 0.5g tocopheryl acetate, 0.2g propylene glycol, 0.01g gentian extract, 0.1g ginger root oil.
The humectant is as follows: a mixture of 4g glycerol, 3g propylene glycol, 0.2g allantoin.
The preparation method of the emulsion preservative comprises the following steps:
into a dry three-neck flask, 6g of acryloyldimethyl taurine, 32g of eugenol, 34g of cysteine, 0.06g of dioctadecylamine, 2.4g of triethanolamine and 240g of ethanol were added; the reaction temperature is controlled at 60 ℃, nitrogen is introduced for protection in the reaction process, the reaction time is 60min, and then ethanol is distilled to obtain the emulsified preservative.
The thermal sensitizer is 0.12g of vanillyl butyl ether.
The thickener is 0.5g of xanthan gum.
The cooling agent is menthol 0.04 g.
The coloring agent is as follows: 0.01g of CI19140, 0.002g of CI16255, 0.0006g of CI42090.
Comparative example 1 was conducted in the same manner as in example 1 except that acryloyldimethyl taurinic acid was not added.
Comparative example 2 eugenol was not added, and the same procedure was followed as in example 1.
Comparative example 3 distearyl amine was not added, otherwise as in example 1.
Through the data analysis of the examples and the comparative examples, the massage cream for relaxing the muscles and joints prepared by the invention can play roles in promoting blood circulation and removing obstruction in collaterals, dispersing blood stasis and relieving pain, soothing and calming skin and the like after lumbar vertebra operation by external rubbing, and can adjust the curative effect of internal and external balance by matching with massage manipulation.
The preferred embodiments of the invention disclosed above are intended only to assist in the explanation of the invention. The preferred embodiments are not intended to be exhaustive or to limit the invention to the precise form disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best understand and utilize the invention. The invention is limited only by the claims and the full scope and equivalents thereof.
Claims (8)
1. A preparation method of the massage cream for relaxing the muscles and joints comprises the following operation steps:
s1: weighing 60-80 parts by weight of water, 0.0001-0.001 part by weight of safflower extract, 0.0001-0.001 part by weight of ginseng root extract, 0.0001-0.001 part by weight of red sage root extract, 0.0001-0.001 part by weight of ligusticum rhizome root extract, 0.0001-0.001 part by weight of radix paeoniae rubra root extract, 0.001-0.003 part by weight of butanediol, 0.001-0.005 part by weight of 1, 2-hexanediol, emollient, humectant, thickener, thermal sensitizer and 0.07-0.7 part by weight of emulsifying preservative, adding into a vacuum emulsifying pot, mixing and stirring for 10-30min;
s2: heating to 50-70deg.C, stirring for 60-90min, homogenizing for 30-60min;
s3: finally, 0.01 to 0.1 part of essence, cooling agent and coloring agent are added and stirred for 10 to 20 minutes to obtain the massage cream for relaxing the muscles and joints.
2. The method for preparing the massage cream for relaxing the muscles and joints according to claim 1, wherein the method comprises the following steps: the emollient is as follows: 1-5 parts of isopropyl palmitate, 0.1-0.5 part of tocopheryl acetate, 0.02-0.2 part of propylene glycol, 0.001-0.01 part of gentian extract and 0.01-0.1 part of ginger root oil.
3. The method for preparing the massage cream for relaxing the muscles and joints according to claim 1, wherein the method comprises the following steps: the humectant is as follows: 1-4 parts of glycerin, 1-3 parts of propylene glycol and 0.02-0.2 part of allantoin.
4. The method for preparing the massage cream for relaxing the muscles and joints according to claim 1, wherein the method comprises the following steps: the preparation method of the emulsion preservative comprises the following steps:
adding 3-6 parts of acryloyldimethyl taurine, 16-32 parts of eugenol, 17-34 parts of cysteine, 0.003-0.06 part of dioctadecylamine, 0.6-2.4 parts of triethanolamine and 200-240 parts of ethanol into a dry three-neck flask according to parts by weight; the reaction temperature is controlled at 50-60 ℃, nitrogen is introduced for protection in the reaction process, the reaction time is 20-60min, and then ethanol is distilled to obtain the emulsified preservative.
5. The method for preparing the massage cream for relaxing the muscles and joints according to claim 1, wherein the method comprises the following steps: the thermal sensitizer is 0.06-0.12 part of vanillyl butyl ether.
6. The method for preparing the massage cream for relaxing the muscles and joints according to claim 1, wherein the method comprises the following steps: the thickener is 0.1-0.5 part of xanthan gum.
7. The method for preparing the massage cream for relaxing the muscles and joints according to claim 1, wherein the method comprises the following steps: the cooling agent is menthol 0.01-0.04 parts.
8. The method for preparing the massage cream for relaxing the muscles and joints according to claim 1, wherein the method comprises the following steps: the coloring agent is as follows: 0.001-0.01 part of CI19140, 0.0005-0.002 part of CI16255, 0.0001-0.0006 part of CI 42090.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410037706.9A CN117547505B (en) | 2024-01-10 | 2024-01-10 | Preparation method of massage cream for relaxing and activating channels and collaterals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410037706.9A CN117547505B (en) | 2024-01-10 | 2024-01-10 | Preparation method of massage cream for relaxing and activating channels and collaterals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117547505A true CN117547505A (en) | 2024-02-13 |
| CN117547505B CN117547505B (en) | 2024-04-05 |
Family
ID=89815061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410037706.9A Active CN117547505B (en) | 2024-01-10 | 2024-01-10 | Preparation method of massage cream for relaxing and activating channels and collaterals |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117547505B (en) |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103330660A (en) * | 2013-06-07 | 2013-10-02 | 郑州市嘉蓓丽贸易有限公司 | Skin-care health-care massage cream for waist and legs and preparation method thereof |
| CN103446001A (en) * | 2013-07-23 | 2013-12-18 | 郑州市嘉蓓丽贸易有限公司 | Skin-caring healthcare massage cream for breasts and production method of skin-caring healthcare massage cream for breasts |
| CN105079760A (en) * | 2015-09-05 | 2015-11-25 | 伊犁州芳香植物研究中心 | Lavender massaging cream for soothing channels and activating collaterals |
| CN107158086A (en) * | 2017-06-06 | 2017-09-15 | 成都华西珐玛生物科技有限公司 | With the skin care/therapeutic combination for alleviating itch effect |
| CN109602888A (en) * | 2019-02-01 | 2019-04-12 | 株洲千金药业股份有限公司 | A kind of abdomen is releived essential oil composition and massage cream and preparation method thereof |
| CN110840754A (en) * | 2019-11-28 | 2020-02-28 | 广州市发雅丝精细化工有限公司 | Anti-dandruff oil-control shampoo and preparation method thereof |
| CN111166788A (en) * | 2020-03-13 | 2020-05-19 | 广州梁启明养生研究有限公司 | Traditional Chinese medicine combined massage cream for promoting blood circulation, dredging collaterals, relieving pain and diminishing inflammation and preparation method thereof |
| WO2022088324A1 (en) * | 2020-10-27 | 2022-05-05 | 乐比(广州)健康产业有限公司 | Massage cream for relieving muscle discomfort |
| CN114903821A (en) * | 2021-07-08 | 2022-08-16 | 包计贤 | A facial mask rich in natural medicine and its preparation method |
| KR20230122277A (en) * | 2022-02-14 | 2023-08-22 | 정직한화장품 협동조합 | Massage cream composition and manufacturing method using sancho |
| KR102611063B1 (en) * | 2023-09-15 | 2023-12-07 | 김유진 | Massage cream composition and method for manufacturing the same. |
-
2024
- 2024-01-10 CN CN202410037706.9A patent/CN117547505B/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103330660A (en) * | 2013-06-07 | 2013-10-02 | 郑州市嘉蓓丽贸易有限公司 | Skin-care health-care massage cream for waist and legs and preparation method thereof |
| CN103446001A (en) * | 2013-07-23 | 2013-12-18 | 郑州市嘉蓓丽贸易有限公司 | Skin-caring healthcare massage cream for breasts and production method of skin-caring healthcare massage cream for breasts |
| CN105079760A (en) * | 2015-09-05 | 2015-11-25 | 伊犁州芳香植物研究中心 | Lavender massaging cream for soothing channels and activating collaterals |
| CN107158086A (en) * | 2017-06-06 | 2017-09-15 | 成都华西珐玛生物科技有限公司 | With the skin care/therapeutic combination for alleviating itch effect |
| CN109602888A (en) * | 2019-02-01 | 2019-04-12 | 株洲千金药业股份有限公司 | A kind of abdomen is releived essential oil composition and massage cream and preparation method thereof |
| CN110840754A (en) * | 2019-11-28 | 2020-02-28 | 广州市发雅丝精细化工有限公司 | Anti-dandruff oil-control shampoo and preparation method thereof |
| CN111166788A (en) * | 2020-03-13 | 2020-05-19 | 广州梁启明养生研究有限公司 | Traditional Chinese medicine combined massage cream for promoting blood circulation, dredging collaterals, relieving pain and diminishing inflammation and preparation method thereof |
| WO2022088324A1 (en) * | 2020-10-27 | 2022-05-05 | 乐比(广州)健康产业有限公司 | Massage cream for relieving muscle discomfort |
| CN114903821A (en) * | 2021-07-08 | 2022-08-16 | 包计贤 | A facial mask rich in natural medicine and its preparation method |
| KR20230122277A (en) * | 2022-02-14 | 2023-08-22 | 정직한화장품 협동조합 | Massage cream composition and manufacturing method using sancho |
| KR102611063B1 (en) * | 2023-09-15 | 2023-12-07 | 김유진 | Massage cream composition and method for manufacturing the same. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117547505B (en) | 2024-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988657B (en) | Plaster for treating fracture and traumatic injury and preparation method of plaster | |
| CN110585351A (en) | External-use bone-setting ointment and preparation method thereof | |
| CN117547505B (en) | Preparation method of massage cream for relaxing and activating channels and collaterals | |
| CN101322786B (en) | External-use medicament for treating bone fracture and traumatic injury | |
| CN106728615A (en) | Chinese medicine composition for synthetism life bone and preparation method thereof | |
| CN110339325A (en) | A kind of exterior-applied medical wine and preparation method thereof for treating rheumatism | |
| CN108272947A (en) | A kind of blood-activating analgesic plaster and preparation method thereof | |
| CN102274372B (en) | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage | |
| US4497823A (en) | Therapeutic method to reduce pain and inflammation | |
| CN113318147A (en) | Formula for relaxing tendons, activating collaterals, eliminating dampness and relieving pain | |
| CN107998235B (en) | Compound Zhuang medicine for treating ankle sprain and preparation method thereof | |
| CN111329921A (en) | Traditional Chinese medicine composition for treating arthralgia and myalgia as well as medicine, preparation method and application thereof | |
| CN111067979A (en) | External traditional Chinese medicine formula for treating shoulder, neck and lumbago | |
| CN104258314A (en) | Traditional Chinese medicine composition for treating epidermis injury and preparation method thereof | |
| CN104524472B (en) | A kind of fracture and pain-stop cream | |
| CN113144018B (en) | Traditional Chinese medicine composition for treating blunt injury of soft tissues and extract and application thereof | |
| CN106474439A (en) | A kind of have heat-clearing and toxic substances removing, the Chinese medicinal ointment of removing heat from blood and promoting blood circulation function and preparation method thereof | |
| CN117482207A (en) | Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction and improving microcirculation and preparation method thereof | |
| CN103239578B (en) | Medicine for treating bone fractures | |
| CN110141636A (en) | A kind of Chinese materia medica preparation and preparation method thereof for treating caput femoris necrosis | |
| CN112741868A (en) | Traditional Chinese medicine composition for stopping bleeding, relieving swelling, promoting blood circulation and removing blood stasis, external liquid medicine and preparation method thereof | |
| CN110721258A (en) | Externally applied medicinal liquor for treating burns and scalds and preparation method thereof | |
| CN114558087A (en) | External application medicine for treating bone fracture | |
| CN105267411B (en) | A kind of pharmaceutical composition for treating fracture | |
| CN112107669A (en) | A Chinese medicinal composition for treating arthritis and synovitis, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |